Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KI1106 in Patients with Dyslipidemia Inadequately Controlled by Atorvastatin
NCT03482180Phase 3Completed
- Sponsor
- Kuhnil Pharmaceutical
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of omega-3-acid ethyl esters + statin in dyslipidemia, sponsored by Kuhnil Pharmaceutical. Started May 2016; status: completed.
02
Drugs
omega-3-acid ethyl esters + statin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03482180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482180.